Skip to content

Aliaxin Ev - Essential Volume (Ukraine)

by Rose Pharma S.A.

Ref Aliaxin Ev - Essential Volume (Ukraine)

Active European Union

CE MDD

Valid until

Not listed

EUDAMED holds no validity date

FDA recalls

Not applicable

No FDA record for this device

Documents

None linked in EUDAMED

A group certificate may exist

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source EUDAMED, synced 25 Oct 2026. What this means

Regulatory status

as of registry sync 25 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/MDD NumberB-07640187920505 Basic UDI-DI 07640187920505UDI-DIDate7 Oct 2026RegisteredStatusActive EUDAMED: not on the EU market

Certificates

0 certificates · EUDAMED

EUDAMED lists no certificate for this device's Basic UDI-DI.

A certificate issued for a device group may exist without being linked here.

Coverage

1 jurisdiction

SwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

European Union — CE/MDD Active

Specification

EUDAMED

Device Name
Intradermal Cross-Linked Ha
Model / Reference
Aliaxin Ev - Essential Volume (Ukraine)
Primary DI / UDI-DI
07640187920505
Basic UDI-DI
B-07640187920505
EMDN Code
P900402 Resorbable filling and reconstruction devices
Device Class
Class III

Manufacturer details

EUDAMED SRN
CH-MF-000033472
Authorised representative
ROSE PHARMA ITALIA S.R.L. IT-AR-000021266

Other devices from Rose Pharma S.A.

See all devices from Rose Pharma S.A. →

Properties

  • Sterile
  • Implantable

Other properties (11)

  • Reusable: No
  • Contains Latex: No
  • Reprocessed: No
  • CMR Substance: No
  • Human-derived: No
  • Human Tissues: No
  • Animal Tissues: No
  • Endocrine Disruptor: No
  • Administering Medicine: No
  • Measuring Function: No
  • Incorporates Medicinal Product: No